Zobrazeno 1 - 10
of 54
pro vyhledávání: '"P L, Antignani"'
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 117(7)
To study an influence of cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease (HD).One hundred and forty patients with HD, I-III stages, were randomized into 2 groups: patients of group 1 received co
Publikováno v:
International angiology : a journal of the International Union of Angiology. 33(4)
The rates of pregnant women with functional symptoms of venous insufficiency who accepted or refused to wear therapeutic compression stockings were evaluated and compared in relation to their clinical evolution and their compliance levels.The observa
Autor:
G, Guarnera, D, Abeni, P L, Antignani, A, Apollonio, F, Conti, P L, Mollo, A, Murgiano, F, Ofria, M, Ruggeri
Publikováno v:
International angiology : a journal of the International Union of Angiology. 33(6)
No study of strong methodology could be found to resolve the controversy of optimal treatment of distal deep venous thrombosis (DDVT). Some inconclusive evidence exists on two approaches to care: anticoagulants and compression therapy or compression
Autor:
K, Roztocil, P L, Antignani
Publikováno v:
International angiology : a journal of the International Union of Angiology. 33(3)
Autor:
P, Poredoš, M, Jezovnik, E, Kalodiki, G, Andreozzi, P-L, Antignani, D, Clement, A, Comerota, J, Fareed, J, Fletcher, Z, Fras, M, Griffin, A, Markel, R, Martini, A, Mignano, A, Nicolaides, G, Novo, S, Novo, K, Roztočil, A, Visona
Publikováno v:
International angiology : a journal of the International Union of Angiology. 34(1)
Peripheral arterial disease (PAD) is one of the most frequent manifestations of atherosclerosis and is associated with atherosclerosis in the coronary and carotid arteries, leading to a highly increased incidence of cardiovascular events. Major risk
Autor:
C, Allegra, P L, Antignani
Publikováno v:
International angiology : a journal of the International Union of Angiology. 33(5)
Several studies have demonstrated the effective antithrombotic action of mesoglycan to treat chronic venous disease (CVD). The study aimed to assess clinical and quality of life (QoL) (CIVIQ 20 questionnaire) improvements in mesoglycan-treated patien
Autor:
B B, Lee, M, Andrade, P L, Antignani, F, Boccardo, N, Bunke, C, Campisi, R, Damstra, M, Flour, I, Forner-Cordero, P, Gloviczki, J, Laredo, H, Partsch, N, Piller, S, Michelini, P, Mortimer, E, Rabe, S, Rockson, A, Scuderi, G, Szolnoky, J L, Villavicencio
Publikováno v:
International angiology : a journal of the International Union of Angiology. 32(6)
Primary lymphedema can be managed effectively as a form of chronic lymphedema by a sequenced and targeted treatment and management program based around a combination of Decongestive Lymphatic Therapy (DLT) with compression therapy, when the latter is
Publikováno v:
International angiology : a journal of the International Union of Angiology. 31(3)
Publikováno v:
International angiology : a journal of the International Union of Angiology. 28(1)
The effectiveness of anticoagulant therapy for venous thromboembolism, with regards to both acute phase and long term prophylaxis, in patients with recurrent deep venous thrombosis (DVT) and persistence of risk factors, has been confirmed by many stu
The optimal treatment of isolated distal deep vein thrombosis (ID-DVT) is still controversial. A complete anticoagulation as soon as the diagnosis is made is recommended by some authors. Alternatively, other authors suggest to perform serial ultrason
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0547cf5b05913f463e0b917e92d7c493
http://hdl.handle.net/11585/73678
http://hdl.handle.net/11585/73678